1. 117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS). Issue 1 (April 2015) Authors: Santini, V.; Almeida, A.; Giagounidis, A.; Gröpper, S.; Jonasova, A.; Vey, N.; Mufti, G.J.; Buckstein, R.; Mittelman, M.; Platzbecker, U.; Shpilberg, O.; Ram, R.; del Canizo, C.; Gattermann, N.; Ozawa, K.; Risueno, A.; MacBeth, K.J.; Zhong, J.; Séguy, F.; Hoenekopp, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 43 A PREDICTIVE MODEL OF RESPONSE TO ERYTHROPOIETIC STIMULATING AGENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. (April 2015) Authors: Houston, B.L.; Jayakar, J.; Lenis, M.; Mamedov, A.; Wells, R.A.; Buckstein, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 73 INCIDENCE AND ALLELE FREQUENCY OF MDS-ASSOCIATED MUTATIONS THROUGH THE SPECTRUM OF CONTROL, EQUIVOCAL AND DIAGNOSTIC MDS BONE MARROWS. (April 2015) Authors: Snetsinger, B.; Heath, E.; Good, D.J.; Buckstein, R.; Wells, R.A.; Rauh, M.J. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Azacitidine Versus Conventional Care Regimens (CCR) in Elderly Patients (≥75 Years) with Acute Myeloid Leukemia (AML) in the AZA-AML-001 Study. (April 2017) Authors: Seymour, J.F.; Buckstein, R.; Santini, V.; Döhner, H.; Stone, R.M.; Minden, M.D.; Kuo, C.Y.; Ben-Yehuda, D.; Bargay, J.; Songer, S.; Weaver, J.; Beach, C.L.; Dombret, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA FOLLOWING RETREATMENT WITH SECOND‐LINE RITUXIMAB‐CONTAINING CHEMOTHERAPY. (12th June 2019) Authors: Liu, J.; Biccler, J.L.; Stewart, D.; Fontaine, A.; Peters, A.; Fleury, I.; Mollica, L.; Prica, A.; Buckstein, R.; Kuruvilla, J.; Villa, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clonal Hematopoiesis of Aging (CHIP) is Associated with Specific Immunological Parameters and Clinical Comorbidities: Toward Practical Screening in Older Adults. (April 2017) Authors: Cook, E.K.; Izukawa, T.; Johnson, D.; Bain, E.; Hilland, J.; Snetsinger, B.; Momtaz, B.; Francis, J.; Young, S.; Rosen, G.; Jamali, M.; Buckstein, J.; Rauh, M.; Buckstein, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis. Issue 8 (2nd August 2016) Authors: Cheung, M. C.; Prica, A.; Graczyk, J.; Buckstein, R.; Chan, K. K. W. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 8(2016:Aug.) Page Start: 1865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis. (April 2017) Authors: Leitch, H.A.; Wells, R.A.; Chodirker, L.; Zhu, N.; Nevill, T.J.; Yee, K.W.L.; Leber, B.; Keating, M.M.; Sabloff, M.; Hilaire, E. St.; Kumar, R.; Delage, R.; Geddes, M.; Storring, J.M.; Shamy, A.; Elemary, M.; Lenis, M.; Francis, J.; Zhang, L.; Buckstein, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MDS-Can-It: A New Validated International ESA-Response Score that Further Refines the Predictive Power of the Nordic Scoring System. (April 2017) Authors: Buckstein, R.; Balleari, E.; Wells, R.A.; Santini, V.; Salvetti, C.; Allione, B.; Danise, P.; Finelli, C.; Clavio, M.; Zhu, N.; Michelle, G.; Sabloff, M.; Leitch, H.; Leber, B.; Luca, M.; Latagliata, R.; Antonietta, M.; Villivà, N.; Piccioni, A.L.; Buccisano, F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Monthly blood transfusions decrease after four months of azacitidine. Issue 2 (20th April 2015) Authors: Tseng, E.; Prica, A.; Zhang, L.; Mittmann, N.; Seung, S. J.; Callum, J.; Kim, T.; Wells, R. A.; Buckstein, R. Journal: Vox sanguinis Issue: Volume 109:Issue 2(2015) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗